SPARK Taiwan - ImmunAdd

Vaccination is proven to be an effective tool in fighting many pathogens. Driven by the market need in the development of therapecutic vaccines, adjuvants are a necessary component of modern vaccines because they can enhance the ability of vaccines to elicit strong, durable, and specific immune responses. But very few adjuvants can efficiently enhance the T-cell responses of vaccines, this has caused vaccines to fail in the past. Our team named “ImmunAdd Therapeutics”, a group of researchers from Spark Taiwan invented a new series of saponin analogs and demonstrated their abilities to enhance vaccine efficacy through increasing antigen-specific CD8+ T-cell mediated immunity. The induction of memory CD8+ T-cell has seen in their combination with anti-cancer vaccines, anti-influenza vaccines, anti-SARS-CoV-2 vaccines.